Fueling Open Innovation for Malaria Transmission-Blocking Drugs: Hundreds of Molecules Targeting Early Parasite Mosquito Stages.

Delves, Michael; Lafuente-Monasterio, M Jose; Upton, Leanna; Ruecker, Andrea; Leroy, Didier; Gamo, Francisco-Javier; Sinden, Robert

Delves, Michael; Lafuente-Monasterio, M Jose; Upton, Leanna; Ruecker, Andrea; Leroy, Didier; Gamo, Francisco-Javier; Sinden, Robert.

Afiliação

Delves M; Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Lafuente-Monasterio MJ; Department of Life Sciences, Imperial College London, London, United Kingdom.
Upton L; Diseases of the Developing World (DDW), GlaxoSmithKline, Tres Cantos, Spain.
Ruecker A; Department of Life Sciences, Imperial College London, London, United Kingdom.
Leroy D; Department of Life Sciences, Imperial College London, London, United Kingdom.
Gamo FJ; Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Sinden R; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.

Front Microbiol ; 10: 2134, 2019.

Article em En | MEDLINE | ID: mdl-31572339

Palavras-chave

drug; malaria; ookinete; screening; transmission

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 3_ND Base de dados: MEDLINE Idioma: En Revista: Front Microbiol Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google